Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Hospitalizations in the United States.

IF 1.2 4区医学 Q3 DERMATOLOGY

Pediatric Dermatology Pub Date : 2026-10-09 DOI:10.1111/pde.70362

Shazli Razi, Priya Agarwal, Gaurav N Pathak, Christian Kaunzinger, Aaron Morgan, Babar K Rao

引用次数: 0

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare life-threatening mucocutaneous reactions that remain poorly characterized in pediatric populations. Using the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database (KID), the prevalence of SJS/TEN hospitalizations declined from 0.02% in 2016 to 0.009% in 2022, with an overall prevalence of 0.014%. Mortality rates among hospitalized patients remained relatively stable, ranging from 1.8% in 2016 to 1.1% in 2019 and 2022. These findings suggest encouraging trends in pediatric SJS/TEN prevalence and survival while emphasizing the importance of comprehensive supportive management.

查看原文本刊更多论文

美国儿童史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的住院治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

6.70%

发文量

269

审稿时长

1 months

期刊介绍： Pediatric Dermatology answers the need for new ideas and strategies for today''s pediatrician or dermatologist. As a teaching vehicle, the Journal is still unsurpassed and it will continue to present the latest on topics such as hemangiomas, atopic dermatitis, rare and unusual presentations of childhood diseases, neonatal medicine, and therapeutic advances. As important progress is made in any area involving infants and children, Pediatric Dermatology is there to publish the findings.